Epidemiology of white matter lesions

Topics in Magnetic Resonance Imaging

Volumn 15, Issue 6, 2004, Pages 365-367

  Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Elderly; Epidemiology; Risk factors; White matter lesions

Indexed keywords

HOMOCYSTEINE;

AGING; AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; BRAIN DISEASE; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; GENETICS; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WHITE MATTER; WHITE MATTER LESION;

AGE FACTORS; AGED; BRAIN DISEASES; HUMANS; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 23244450476     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000168216.98338.8d     Document Type: Review

References (35)

1. de Groot JC, de Leeuw F-E, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47:145-151.
2. Tell GS, Lefkowitz DS, Diehr P, et al. Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. Arch Neurol. 1998;55:73-79.
3. Carmelli D, DeCarli C, Swan GE, et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci. 2000;55:M103-M109.
4. Steffens DC, Helms MJ, Krishnan RR, et al. Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke. 1999;30:2159-2166.
5. Vermeer SE, Hollander M, van Dijk EJ, et al. Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129.
6. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427-434.
7. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997;16:149-162.
8. de Leeuw F-E, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70:9-14.
9. Launer LJ, Oudkerk M, Nilsson L-G, et al. CASCADE: A European collaborative study on vascular determinants of brain lesions. Study design and Objectives. Neuroepidemiology. 2000;19:113-120.
10. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke. 1996;27:2262-2270.
11. Havlik R, Foley DJ, Sayer B, et al. Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: The Honolulu Asia Aging Study. Stroke. 2002;33:26-30.
12. de Leeuw FE, de Groot JC, Oudkerk M, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol. 1999;46:827-833.
13. Dufouil C, de Kersaint-Gilly A, Besançon V, et al. Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI cohort. Neurology. 2001;56:921-926.
14. van Dijk EJ, Breteler MM, Schmidt R, et al. The association between blood pressure, hypertension, and cerebral white matter lesions. The Cardiovascular Determinants of Dementia Study. Hypertension. 2004;44:625-630.
15. de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke. 2004;35:1057-1060.
16. de Leeuw F-E, de Groot JC, Oudkerk M, et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology. 2000;54:1795-1800.
17. Veldink JH, Scheltens Ph, Jonker C, et al. Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology. 1998;51:319-320.
18. Schmidt R, Enzinger C, Ropele S, et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet. 2003;361:2046-2048.
19. Manolio TA, Burke GL, O'Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:356-365.
20. Schmidt R, Launer LJ, Nilsson LG, et al. Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes. 2004;53:687-692.
21. de Leeuw FE, de Groot JC, Bots ML, et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol. 2000;247:291-296.
22. de Leeuw FE, De Groot JC, Oudkerk M, et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke. 2000;31:425-429.
23. Pico F, Dufouil C. Levy C, et al. Longitudinal study of carotid atherosclerosis and white matter hyperintensities: the EVA-MRI cohort. Cerebrovasc Dis. 2002;14:109-115.
24. den Heijer T, Launer LJ, de Groot JC, et al. Serum carotenoids and cerebral white matter lesions: the Rotterdam scan study. J Am Geriatr Soc. 2001;49:642-646.
25. Schmidt R, Schmidt H, Fazekas F, et al. MRI cerebral white matter lesions and paraoxonase PONl polymorphisms: three-year follow-up of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Dial. 2000;20:1811-1816.
26. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
27. Longstreth WT Jr, Katz R, Olson J, et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol. 2004;61:67-72.
28. Hademenos GJ, Alberts MJ, Awad I, et al. Advances in the genetics of stroke. Neurology. 2001;56:997-1008.
29. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in while matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177-1181.
30. Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Bone. 2004;35:1609-1613.
31. Schmidt R, Schmidt H, Fazekas F, et al. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension. 2001;38:110-115.
32. Schmidt H, Fazekas F, Kostner GM, et al. Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke. 2001;32:405-412.
33. Kohara K, Fujisawa M, Ando F, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NlLS-LSA Study. Stroke. 2003;34:1130-1135.
34. Ding J, Nieto FJ. Beauchamp NJ, et al. A prospective analysis of risk factors for white matter disease in the brain stem: the Cardiovascular Health Study. Neuroepidemiology. 2003;22:275-282.
35. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246-253.